A first in human, safety, pharmacokinetics, and clinical activity phase I study of once weekly administration of the Hsp90 inhibitor ganetespib (STA-9090) in patients with solid malignancies (Q34636437)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A first in human, safety, pharmacokinetics, and clinical activity phase I study of once weekly administration of the Hsp90 inhibitor ganetespib (STA-9090) in patients with solid malignancies |
scientific article |
Statements
1 reference
A first in human, safety, pharmacokinetics, and clinical activity phase I study of once weekly administration of the Hsp90 inhibitor ganetespib (STA-9090) in patients with solid malignancies (English)
1 reference
Jonathan W Goldman
1 reference
Robert N Raju
1 reference
Gregory A Gordon
1 reference
Iman El-Hariry
1 reference
Florentina Teofilivici
1 reference
Vojo M Vukovic
1 reference
Robert Bradley
1 reference
Michael D Karol
1 reference
Yu Chen
1 reference
Wei Guo
1 reference
Takayo Inoue
1 reference
Lee S Rosen
1 reference
25 March 2013
1 reference
1 reference
13
1 reference
152
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference